GINA BATTAGLIA, PH.D.

Oncolytic, or engineered, viruses that infect and kill cancer cells are showing promise.

More and more, treating HER2-positive breast cancers involves combining an array of drugs.

According to a recent analysis of a large national database, patients with a history of breast cancer have a higher risk of developing thyroid cancer than the general population, particularly if they receive adjuvant radiation therapy.